Skip to main content

AustraliaBreaking News

Grafa

DAYBU nears EU green light, unlocking US$35m upfront for Neuren Pharmaceuticals

Neuren Pharmaceuticals (ASX:NEU) says the European Medicines Agency’s CHMP has adopted a positive opinion, after re‑examination, recommending the European Commission grant marketing authorisation for DAYBU (trofinetide) to treat neurobehavioral symptoms of Rett syndrome in adults and children aged five and over.

Read more
Grafa

Strategic Energy Resources (ASX:SER) raises A$1.5m to fund Diamantina drilling

Strategic Energy Resources (ASX:SER) has received firm commitments to raise A$1.5 million before costs through a A$1.25 million share placement and an expected fully underwritten A$0.25 million share purchase plan at A$0.12 per share to fund drilling and exploration at its Diamantina Copper‑Gold Project in Queensland.

Read more
Bloomberg

Kent on Reserve Bank of Australia's New Framework

Australian central bank Assistant Governor Chris Kent said the institution will be better prepared to respond to the next crisis it faces following a review of alternative monetary policy tools. In a speech in Sydney, Kent, who oversees financial markets at the Reserve Bank, said the cash rate target remains the primary and preferred instrument, but additional tools can play an important role during extraordinary times and provide some extra support.

Read more